Skip to main content
OpenTrials
Completed

NCT Number: NCT01612182

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

End-stage Renal Disease Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year–79 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Inje University Seoul Paik hospital Instituional Board Review

Seoul, Je Dong 2ga, Jung Gu, 100-032, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The age of patient was between 18 yrs and 79 yrs.
  • The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization

Exclusion criteria

  • The level of serum albumin was below 2.0 or over 5.0
  • The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month.
  • The level of Body mass index was below 15 or over 30
  • Pregnancy

Treatment and study plan

renal replacement therapy

Other

renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )

Primary outcomes

  1. The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy

    Time frame: During hospitalization

    The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

Secondary outcomes

  1. The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy

    Time frame: during hospitalization

    The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

Sponsors and collaborators

Lead sponsor

Inje University

Other

Registry information

Important dates

Study start
2012
Study completion
2012
First posted
Jun 5, 2012
Registry last updated
Jun 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.